OBJECTIVE: To estimate the effect of low-dose aspirin started in early pregnancy on the
incidence of preeclampsia and intrauterine growth restriction (IUGR). DATA SOURCES: A …

Hypertensive disorders of pregnancies remain a central public health concern throughout
the world, and are a major cause of maternal mortality in the developing world. Although …

Background Oxidative stress has been proposed as a mechanism linking the poor placental
perfusion characteristic of preeclampsia with the clinical manifestations of the disorder. We …

Hypertension complicates 5% to 7% of all pregnancies. A subset of preeclampsia,
characterized by new-onset hypertension, proteinuria, and multisystem involvement, is …

Geared to residents and fellows in nephrology, internal medicine, and other specialties, this
classic text bridges the gap between basic and clinical sciences for the many disorders …

Hypertensive disorders in pregnancy can be chronic, pregestational or just diagnosed
before the 20th week, or newly diagnosed in the second half of pregnancy. Any type of …

Aspirin is widely used internationally for a variety of indications, with the most prominent one
being that of cardiovascular disease. However, aspirin has also been proposed as a …

Background Hypertensive disease in pregnancy remains the leading cause of maternal
mortality in the Netherlands. Seventeen percent of the clinical pregnancies are complicated …

Aspirin has shown efficacy in preventing PE with a 10% incidence reduction. The treatment
must be started between the 12th and 14th week of amenorrhea with a dose of 75 to 160mg …

The Objective of this study was to evaluate the vitamin A, C, E and beta carotene intakes and
preeclampsia among pregnant women. The data were analyzed from 30 pregnant women …